Serum HMGB1 as a prognostic marker for malignant pleural mesothelioma (Q34687224)

3 August 2017

Serum HMGB1 as a prognostic marker for malignant pleural mesothelioma (English)

1 reference

malignant pleural mesothelioma

3 August 2017

1 reference

Chiharu Tabata

1

1 reference

3 August 2017

Eisuke Shibata

2

1 reference

3 August 2017

Rie Tabata

3

1 reference

3 August 2017

Shingo Kanemura

4

1 reference

3 August 2017

Koji Mikami

5

1 reference

3 August 2017

Yoshitaka Nogi

6

1 reference

3 August 2017

Eriko Masachika

7

1 reference

3 August 2017

Tomoyuki Nishizaki

8

1 reference

3 August 2017

Takashi Nakano

9

1 reference

3 August 2017

language of work or name

English

0 references

publication date

24 April 2013

1 reference

3 August 2017

1 reference

3 August 2017

13

1 reference

3 August 2017

205

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2407-13-205

3 August 2017

0 references

cites work

Serum mesothelin for diagnosing malignant pleural mesothelioma: an individual patient data meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3644247

Molecular pathways: targeting mechanisms of asbestos and erionite carcinogenesis in mesothelioma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3644247

Malignant mesothelioma: facts, myths, and hypotheses

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3644247

High-mobility group box 1 and cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3644247

High-mobility group box 1-mediated matrix metalloproteinase-9 expression in non-small cell lung cancer contributes to tumor cell invasiveness

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3644247

Occupational, domestic and environmental mesothelioma risks in the British population: a case-control study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3644247

Modulated inflammation by injection of high-mobility group box 1 recovers post-infarction chronically failing heart

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3644247

Potential role of high-mobility group box 1 in cystic fibrosis airway disease.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3644247

Masquerader: high mobility group box-1 and cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3644247

Role of HMGB1 in apoptosis-mediated sepsis lethality

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3644247

TNF-alpha inhibits asbestos-induced cytotoxicity via a NF-kappaB-dependent pathway, a possible mechanism for asbestos-induced oncogenesis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3644247

Advances in malignant mesothelioma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3644247

Increased expression of high mobility group box 1 (HMGB1) is associated with an elevated level of the antiapoptotic c-IAP2 protein in human colon carcinomas

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3644247

High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3644247

Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3644247

Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3644247

HMGB1 inhibits cell death in yeast and mammalian cells and is abundantly expressed in human breast carcinoma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3644247

Upregulation of HMG1 leads to melanoma inhibitory activity expression in malignant melanoma cells and contributes to their malignancy phenotype

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3644247

Release of chromatin protein HMGB1 by necrotic cells triggers inflammation

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3644247

New approaches for mesothelioma: biologics, vaccines, gene therapy, and other novel agents

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3644247

The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3644247

A proposed new international TNM staging system for malignant pleural mesothelioma. From the International Mesothelioma Interest Group

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3644247

Specific recognition of cruciform DNA by nuclear protein HMG1.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3644247

The role of high mobility group box1 in pulmonary fibrosis

7 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-205

Mesothelin-family proteins and diagnosis of mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-205

The role of the receptor for advanced glycation end-products in lung fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-205

Blockade of RAGE–amphoterin signalling suppresses tumour growth and metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-205

High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23617783

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Latency of asbestos disease among insulation workers in the United States and Canada

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23617783

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Malignant mesothelioma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23617783

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1471-2407-13-205

1 reference

Dimensions Publication ID

3 August 2017

0 references

1 reference

3 August 2017

1 reference